• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阴茎海绵体内自体注射前列腺素E1用于勃起功能障碍的诊断与治疗]

[Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].

作者信息

Arielly J, Weinberg D, Eliraz A, Adam M, el-Hanani B I, Eisenkraft S

机构信息

Urology Dept., Kaplan Hospital, Rehovot.

出版信息

Harefuah. 1994 Apr 1;126(7):369-73, 426.

PMID:8200581
Abstract

34 impotent patients were offered auto-injection therapy and all except 2 began treatment. Prostaglandin E1 (PGE) was used regularly for a mean of 8.6 months (range 1-17). The onset of erection was 5-30 min (mean 11.4) after injection and it lasted at least 30 min (mean 106.2 min). An erection of more than 6 hrs was observed in only 2 patients. There have been no instances of cavernous fibrosis, chemical priapism or systemic reactions. The most common adverse effect was penile pain after injection. It was mild to moderate in 4 patients (11.7%), and in only 1 was it severe enough to require stopping treatment. Overall, intracavernous injection of PGE appears to be safe, effective treatment for impotence without side-effects other than pain after injection in a few.

摘要

34名阳痿患者接受了自我注射疗法,除2人外其余均开始治疗。前列腺素E1(PGE)被常规使用,平均使用时间为8.6个月(范围1 - 17个月)。注射后勃起开始时间为5 - 30分钟(平均11.4分钟),勃起持续至少30分钟(平均106.2分钟)。仅2例患者出现勃起超过6小时的情况。未发生海绵体纤维化、化学性阴茎异常勃起或全身反应。最常见的不良反应是注射后阴茎疼痛。4例患者(11.7%)疼痛为轻至中度,仅1例严重到需要停止治疗。总体而言,海绵体内注射PGE似乎是一种安全、有效的阳痿治疗方法,除少数患者注射后疼痛外无其他副作用。

相似文献

1
[Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].[阴茎海绵体内自体注射前列腺素E1用于勃起功能障碍的诊断与治疗]
Harefuah. 1994 Apr 1;126(7):369-73, 426.
2
Cavernous auto-injection therapy with prostaglandin E1.
Ann Chir Gynaecol Suppl. 1993;206:69-73.
3
[Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
Arch Ital Urol Nefrol Androl. 1991 Dec;63(4):481-5.
4
[Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].[经海绵体内注射前列腺素E1治疗性功能障碍。180例患者的报告]
Prog Urol. 1993 Dec;3(6):971-8.
5
Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.脊髓损伤所致勃起功能障碍患者海绵体内注射前列腺素E1:初步报告
Paraplegia. 1995 Dec;33(12):731-3. doi: 10.1038/sc.1995.153.
6
[Intracavernous pharmacotherapy for treatment and evaluation of impotence].[阴茎海绵体内药物治疗用于阳痿的治疗与评估]
Harefuah. 1991 Oct;121(7-8):223-5.
7
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].[海绵体内注射前列腺素E1与罂粟碱或罂粟碱酚妥拉明在勃起功能障碍诊断和治疗中的有效性及副作用的前瞻性研究。文献综述]
Actas Urol Esp. 1992 Mar;16(3):208-16.
8
[Prostaglandin E1 in the diagnosis and therapy of erectile disorders].[前列腺素E1在勃起功能障碍的诊断与治疗中]
Urol Nefrol (Mosk). 1995 Jul-Aug(4):35-8.
9
Prostaglandin E1 in the therapy of erectile deficiency.
Acta Eur Fertil. 1989 Sep-Oct;20(5):305-8.
10
Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.中国经皮腔内自我注射前列腺素 E1 治疗勃起功能障碍的长期疗效和安全性。
Andrologia. 2011 Jun;43(3):208-12. doi: 10.1111/j.1439-0272.2010.01091.x. Epub 2011 Mar 25.